CytoSorbents Q3 EPS $(0.21) Beats $(0.22) Estimate, Sales $6.1M Miss $6.66M Estimate

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 110 percent decrease over losses of $(0.1) per share from the same

Benzinga · 11/05/2019 21:40

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 110 percent decrease over losses of $(0.1) per share from the same period last year. The company reported quarterly sales of $6.1 million which missed the analyst consensus estimate of $6.66 million by 8.41 percent. This is a 6.22 percent increase over sales of $5.743 million the same period last year.